Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients

Free Radical Biology and Medicine

Volumn 29, Issue 8, 2000, Pages 790-792

  Devaraj, Sridevi ^a   Jialal, Ishwarlal ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alpha tocopherol; Diabetes; Free radicals; Inflammation; Monocytes

Indexed keywords

ALPHA TOCOPHEROL; C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; ATHEROGENESIS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PRIORITY JOURNAL; SERUM; SUPPLEMENTATION;

ANTIOXIDANTS; ARTERIOSCLEROSIS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; HUMANS; INTERLEUKIN-6; MONOCYTES; VITAMIN E;

EID: 0034667579     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(00)00420-2     Document Type: Article

References (9)

1. Novel inflammatory markers of coronary risk; theory versus practice
2. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women
3. Body mass index, diabetes, and C-reactive protein among U.S. adults
4. The pathophysiologic roles of interleukin-6 in human disease
5. Is type II diabetes mellitus a disease of the innate immune system?
6. The effect of alpha tocopherol on crucial cells in atherogenesis
7. LDL post-secretory modification, monocyte function and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications; effect of alpha tocopherol supplementation
8. Vitamin E and heart disease; basic science to clinical intervention trials
9. Vitamin E supplementation and cardiovascular events in high-risk patients